Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction sub-type and infarction volume

International Journal of Medical Sciences

Volumn 10, Issue 1, 2012, Pages 103-109

  Kim, Seo Hyun ^a   Lee, Ji Yong ^a   Park, Sang Hyun ^a   Jang, Hyun Chan ^a   Lim, Eun Ju ^a   Chang, Sei Jin ^a   Lee, Sung Soo ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Brain natriuretic peptide; Cardiovascular diseases; Cerebral infarction; Embolism; Etiology; Infarction volume

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CARDIOEMBOLIC STROKE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING;

BRAIN NATRIURETIC PEPTIDE; CARDIOVASCULAR DISEASES; CEREBRAL INFARCTION; EMBOLISM; ETIOLOGY; INFARCTION VOLUME;

AGED; C-REACTIVE PROTEIN; CEREBRAL INFARCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; STROKE VOLUME;

EID: 84872155489     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5005     Document Type: Article

References (35)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998; 339: 321-8.
2. Mair J. Biochemistry of B-type natriuretic peptide--where are we now? Clin Chem Lab Med. 2008; 46: 1507-14.
3. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007; 50: 2357-68.
4. Balion CM, Santaguida P, McKelvie R, Hill SA, McQueen MJ, Worster A, et al. Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clin Biochem. 2008; 41: 231-9.
5. Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT. Novel diagnostic test for acute stroke. Stroke. 2004; 35: 57-63.
6. Nakagawa K, Yamaguchi T, Seida M, Yamada S, Imae S, Tanaka Y, et al. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis. 2005; 19: 157-64.
7. Cakir Z, Saritas A, Emet M, Aslan S, Akoz A, Gundogdu F. A prospective study of brain natriuretic peptide levels in three subgroups: Stroke with hypertension, stroke without hypertension, and hypertension alone. Ann Indian Acad Neurol. 2010; 13: 47-51.
8. Di Angelantonio E, De Castro S, Toni D, Sacchetti ML, Biraschi F, Prencipe M, et al. Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA. J Neurol Sci. 2007; 260: 139-42.
9. Makikallio AM, Makikallio TH, Korpelainen JT, Vuolteenaho O, Tapanainen JM, Ylitalo K, et al. Natriuretic peptides and mortality after stroke. Stroke. 2005; 36: 1016-20.
10. Shibazaki K, Kimura K, Okada Y, Iguchi Y, Uemura J, Terasawa Y, et al. Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Intern Med. 2009; 48: 1601-6.
11. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24: 35-41.
12. LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides. 2005; 26: 944-56.
13. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL, Jr. Biology of the natriuretic peptides. Am J Cardiol. 2008; 101: 3-8.
14. Porzionato A, Macchi V, Rucinski M, Malendowicz LK, De Caro R. Natriuretic peptides in the regulation of the hypothalamic-pituitary-adrenal axis. Int Rev Cell Mol Biol. 2010; 280: 1-39.
15. Myers MG, Norris JW, Hachinski VC, Weingert ME, Sole MJ. Cardiac sequelae of acute stroke. Stroke. 1982; 13: 838-42.
16. Schwarz S, Schwab S, Klinga K, Maser-Gluth C, Bettendorf M. Neuroendocrine changes in patients with acute space occupying ischaemic stroke. J Neurol Neurosurg Psychiatry. 2003; 74: 725-7.
17. Fassbender K, Schmidt R, Mossner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke. 1994; 25: 1105-8.
18. Fujishima S, Abe I, Okada Y, Saku Y, Sadoshima S, Fujishima M. Serial changes in blood pressure and neurohormone levels after the onset of lacunar stroke. Angiology. 1996; 47: 579-87.
19. Myers MG, Norris JW, Hachniski VC, Sole MJ. Plasma norepinephrine in stroke. Stroke. 1981; 12: 200-4.
20. Koenig M, Puttgen H, Prabhakaran V, Reich D, Stevens R. B-type natriuretic peptide as a marker for heart failure in patients with acute stroke. Intensive Care Med. 2007; 33: 1587-93.
21. Clerico A, Giannoni A, Vittorini S, Passino C. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol. 2011; 301:H12-20.
22. Shi H. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem. 2009; 16: 4593-600.
23. Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, et al. Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J. 2008; 409: 233-42.
24. Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacon P, Rosell A, et al. Etiologic diagnosis of ischemic stroke subtypes with pasma biomarkers. Stroke. 2008; 39: 2280-7.
25. Shibazaki K, Kimura K, Iguchi Y, Okada Y, Inoue T. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Inten Med. 2009; 48: 259-64.
26. Okada Y, Shibazaki K, Kimura K, Matsumoto N, Iguchi Y, Aoki J, et al. Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation. J Neurol Sci. 2011; 301: 86-9.
27. Shibazaki K, Kimura K, Okada Y, Iguchi Y, Terasawa Y, Aoki J. Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: A brain natriuretic peptide study. J Neurol Sci. 2009; 281: 55-7.
28. Kimura K, Shibazaki K, Iguchi Y, Aoki J, Sakai K, Sakamoto Y, et al. The combination of elevated BNP and AF as a predictor of no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci. 2010; 290: 37-40.
29. Jensen JK, Atar D, Kristensen SR, Mickley H, Januzzi Jr JL. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. The Am J Cardiol. 2009; 104: 287-91.
30. Casco VH, Veinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem. 2002; 50: 799-809.
31. Ashley KE, Galla JM, Nicholls SJ. Brain natriuretic peptides as biomarkers for atherosclerosis. Prev Cardiol. 2008; 11: 172-6.
32. Clerico A, Fontana M, Vittorini S, Emdin M. The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. Clin Chim Acta. 2009; 405: 1-7.
33. Cao LH, Yang XL. Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol. 2008; 84: 234-48.
34. Brosnan MJ, Clark JS, Jeffs B, Negrin CD, Van Vooren P, Arribas SM, et al. Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension. 1999; 33: 290-7.
35. Lee BI, Nam HS, Heo JH, Kim DI. Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis. 2001; 12: 145-51.